Literature DB >> 18065200

The MHC type 1 diabetes susceptibility gene is centromeric to HLA-DQB1.

Zaheed Husain1, M Ann Kelly, George S Eisenbarth, Alberto Pugliese, Zuheir L Awdeh, Charles E Larsen, Chester A Alper.   

Abstract

HLA-DQB1 is widely considered to be the major histocompatibility complex (MHC) susceptibility gene for type 1 diabetes (T1D). However, since inheritance of the gene in T1D is recessive, the presence of the protective HLA-DQB1 0602 allele with normal nucleotide sequence in some patients raises the question of whether HLA-DQB1 is not the susceptibility locus itself but merely a good marker. HLA-DQB1 0602 is part of a conserved extended haplotype (CEH) [HLA-B7, SC31, DR2] (B7, DR2) with fixed DNA over more than 1Mb of genomic DNA that normally carries a protective allele at the true susceptibility locus. We postulated that, in patients with HLA-DQB1 0602, the protective allele at the susceptibility locus has been replaced by a susceptibility allele through an ancient crossover at meiosis centromeric to HLA-DQB1. We analyzed single nucleotide polymorphisms (SNPs) distinguishing the HLA-DQA2 (the first expressed gene centromeric to HLA-DQB1) allele on the normal HLA-B7, DR2 CEH from those on susceptibility CEHs in T1D patients and controls with HLA-DQB1 0602. All but 1 of 20 healthy control HLA-DQB1 0602 haplotypes had identical (consensus) first intron HLA-DQA2 5-SNP haplotypes. Fifteen of 19 patients with HLA-DQB1 0602 were homozygous for 1 or more HLA-DQA2 SNPs differing from consensus HLA-DQA2 SNPs, providing evidence of crossover involving the HLA-DQA2 locus. The remaining 4 patients were heterozygous at all positions and therefore uninformative. The loss of dominant protection usually associated with HLA-DQB1 0602 haplotypes is consistent with a locus centromeric to HLA-DQB1 being a major determinant of MHC-associated susceptibility, and perhaps the true T1D susceptibility locus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18065200     DOI: 10.1016/j.jaut.2007.10.006

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  8 in total

1.  BOOST: A fast approach to detecting gene-gene interactions in genome-wide case-control studies.

Authors:  Xiang Wan; Can Yang; Qiang Yang; Hong Xue; Xiaodan Fan; Nelson L S Tang; Weichuan Yu
Journal:  Am J Hum Genet       Date:  2010-09-10       Impact factor: 11.025

2.  Novel gene associations in type 1 diabetes.

Authors:  Jorma Ilonen; Robert Hermann
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

Review 3.  Extreme genetic risk for type 1A diabetes in the post-genome era.

Authors:  Erin E Baschal; George S Eisenbarth
Journal:  J Autoimmun       Date:  2008-05-01       Impact factor: 7.094

Review 4.  Human leukocyte antigen in primary biliary cirrhosis: an old story now reviving.

Authors:  Pietro Invernizzi
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

5.  Plasma homocysteine levels, the prevalence of methylenetetrahydrofolate reductase gene C677T polymorphism and macrovascular disorders in systemic sclerosis: risk factors for accelerated macrovascular damage?

Authors:  Szilvia Szamosi; Zoltán Csiki; Edit Szomják; Erzsébet Szolnoki; Gabriella Szoke; Zoltán Szekanecz; Gyula Szegedi; Yehuda Shoenfeld; Gabriella Szucs
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

6.  Exploring the diabetogenicity of the HLA-B18-DR3 CEH: independent association with T1D genetic risk close to HLA-DOA.

Authors:  I Santin; A Castellanos-Rubio; A M Aransay; G Gutierrez; S Gaztambide; I Rica; J L Vicario; J A Noble; L Castaño; J R Bilbao
Journal:  Genes Immun       Date:  2009-05-21       Impact factor: 2.676

7.  Improving power of genome-wide association studies with weighted false discovery rate control and prioritized subset analysis.

Authors:  Wan-Yu Lin; Wen-Chung Lee
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

8.  A Mediation Approach to Discovering Causal Relationships between the Metabolome and DNA Methylation in Type 1 Diabetes.

Authors:  Tim Vigers; Lauren A Vanderlinden; Randi K Johnson; Patrick M Carry; Ivana Yang; Brian C DeFelice; Alexander M Kaizer; Laura Pyle; Marian Rewers; Oliver Fiehn; Jill M Norris; Katerina Kechris
Journal:  Metabolites       Date:  2021-08-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.